These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31005061)

  • 21. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
    Kodityal S; Manhas AH; Udden M; Rice L
    Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia.
    Krzych ŁJ; Nowacka E; Knapik P
    Anaesthesiol Intensive Ther; 2015; 47(1):63-76. PubMed ID: 25751293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
    Crowther MA; Cook DJ; Albert M; Williamson D; Meade M; Granton J; Skrobik Y; Langevin S; Mehta S; Hebert P; Guyatt GH; Geerts W; Rabbat C; Douketis J; Zytaruk N; Sheppard J; Greinacher A; Warkentin TE;
    J Crit Care; 2010 Jun; 25(2):287-93. PubMed ID: 20149589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.
    Crowther M; Cook D; Guyatt G; Zytaruk N; McDonald E; Williamson D; Albert M; Dodek P; Finfer S; Vallance S; Heels-Ansdell D; McIntyre L; Mehta S; Lamontagne F; Muscedere J; Jacka M; Lesur O; Kutsiogiannis J; Friedrich J; Klinger JR; Qushmaq I; Burry L; Khwaja K; Sheppard JA; Warkentin TE; ; ;
    J Crit Care; 2014 Jun; 29(3):470.e7-15. PubMed ID: 24726205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentation of heparin-induced thrombocytopenia.
    Warkentin TE
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):9-16; discussion 35-6. PubMed ID: 9855179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiology for the primary care provider: heparin-induced thrombocytopenia.
    Benton RE; Gersh BJ
    South Med J; 1998 Feb; 91(2):133-7. PubMed ID: 9496863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia in medical surgical critical illness.
    Warkentin TE; Sheppard JI; Heels-Ansdell D; Marshall JC; McIntyre L; Rocha MG; Mehta S; Davies AR; Bersten AD; Crozier TM; Ernest D; Vlahakis NE; Hall RI; Wood GG; Poirier G; Crowther MA; Cook DJ;
    Chest; 2013 Sep; 144(3):848-858. PubMed ID: 23722881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-induced thrombocytopenia in neonates.
    Martchenke J; Boshkov L
    Neonatal Netw; 2005; 24(5):33-7. PubMed ID: 16279053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.
    Lubenow N; Kempf R; Eichner A; Eichler P; Carlsson LE; Greinacher A
    Chest; 2002 Jul; 122(1):37-42. PubMed ID: 12114336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on heparin-induced thrombocytopenia: diagnosis and management.
    Bakchoul T
    Expert Opin Drug Saf; 2016 Jun; 15(6):787-97. PubMed ID: 26966871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.